These mechanisms, in addition to the inhibition of the tumor intrinsic effect of Foxp3, could be mediating the antitumor efficacy of Ad.P60, which decreased tumor growth in vivo in BRCA preclinical models and reduced spontaneous lung metastases. This evidence concerns the gene FOXP3 and neoplasm.